Skip to content

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System (Implant and Instrumentation) - A Retrospective Consecutive Series Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05215626
Enrollment
78
Registered
2022-01-31
Start date
2022-08-01
Completion date
2024-12-12
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acetabulum Fracture, Pelvic Ring Fracture

Keywords

Acetabulum Fracture, Pelvic Ring Fracture, Medical Device, Clinical Benefits, Safety, Performance, Post Market Clinical Follow Up Study

Brief summary

The study is a monocentric, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the Reconstruction System (implants and instrumentation) when used for temporary internal fixation and stabilization of fractures during the normal healing process. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objectives are the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. Subjects' outcomes will also be assessed.

Detailed description

The Reconstruction System is especially used to stabilize pelvic ring and acetabulum fractures. One site will be involved in this study. The aim is to include a maximum of 83 consecutive series cases who received the Zimmer Reconstruction System at the Azienda Ospedaliero Universitaria Senese (Siena, Italy) between 2010 and 2018. All potential study subjects will be required to participate to the Informed Consent process. Baseline data from the preop, intraop, immediate post-op and last consultation visit will be available in medical notes and collected retrospectively. In addition, any complications since the last consultation visit at the clinic and information about the treatment of the complications will also be collected retrospectively.

Interventions

None listed

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients having received the Zimmer Reconstruction System for temporary internal fixation and stabilization of fractures during the normal healing process

Exclusion criteria

* Off-label use * Patients under the age of 18 * Severely comminuted fractures in which bone fragments are too small or numerous to adequately fix or maintain a reduced position * Infection * Metal sensitivity or intolerance * Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor-like condition of the bone which may compromise fixation * Sternal or spinal fractures * Anatomical location in which the device would interfere with nerves, blood vessels, or other vital structures * Patients with inadequate soft tissue coverage at the implant site

Design outcomes

Primary

MeasureTime frameDescription
Performance: Fracture HealingMean time of 1.99 years after the surgeryPerformance will be assessed by analyzing fracture healing radiographically by X-rays.

Secondary

MeasureTime frameDescription
Product SafetyMean time of 1.99 years after the surgerySafety will be assessed by recording and analyzing the incidence and frequency of complications during the study
Harris Hip ScoreMean time of 1.99 years after the surgeryClinical benefits will be assessed by evaluating the Harris Hip Score (HHS). The HHS consists of four subscales (pain, function, the absence of deformity and range of motion). The survey has 10 question items and the score will range from 0 (worst) to 100 (best).

Countries

Italy

Contacts

STUDY_DIRECTOREmilie Rohmer

Zimmer Biomet

Participant flow

Recruitment details

Azienda Ospedaliero Universitaria Senese, Siena, Italy

Pre-assignment details

78 consecutive patients (84 cases) were identified at the Azienda Ospedaliero Universitaria Senese and were enrolled in this study

Baseline characteristics

Characteristic
Age, Continuous46.89 years
STANDARD_DEVIATION 16.21
Anatomical location
62A1.1: simple fracture
2 Cases
Anatomical location
62A1.2: multifragmentary fracture
5 Cases
Anatomical location
62A1: posterior wall fracture with or without marginal impaction
9 Cases
Anatomical location
62A2.1: with ischial bone involvement
6 Cases
Anatomical location
62A2.2: with obturator ring involvement
2 Cases
Anatomical location
62A2.3: with simple or multifragmentary posterior wall fracture and possible marginal impaction
2 Cases
Anatomical location
62A2: posterior column fracture
8 Cases
Anatomical location
62A3.2: high anterior column fracture through the iliac crest
9 Cases
Anatomical location
62A3.3: low anterior column fracture below the anterior superior iliac spine
5 Cases
Anatomical location
62A3: anterior wall or column fracture with or without marginal impaction
1 Cases
Anatomical location
62B1: transverse fracture ± posterior wall fracture ± marginal impaction
7 Cases
Anatomical location
62B2: T-fracture ± posterior wall fracture ± marginal impaction
1 Cases
Anatomical location
62B3: posterior hemitransverse and anterior wall or column fracture
1 Cases
Anatomical location
B1: open-book injury (external rotation)
14 Cases
Anatomical location
B2-1: ipsilateral anterior and posterior injuries
8 Cases
Anatomical location
B2-2: contralateral (bucket-handle) injuries
2 Cases
Anatomical location
B2: lateral-compression injury (internal rotation)
2 Cases
BMI25.92 kg/m^2
STANDARD_DEVIATION 3.32
Concomitant diseases
None
79 Cases
Concomitant diseases
Osteoporosis
1 Cases
Concomitant diseases
Others
4 Cases
Confounders for bone union
Comminution of bone
2 Cases
Confounders for bone union
Frailty
7 Cases
Confounders for bone union
High energy accident
45 Cases
Confounders for bone union
None
26 Cases
Confounders for bone union
Others
2 Cases
Confounders for bone union
Smoking
2 Cases
Existence of additional fractures at the time of hospital admission
No
8 Cases
Existence of additional fractures at the time of hospital admission
Yes
76 Cases
Fracture Cause
Fall from height
8 Cases
Fracture Cause
Motor vehicle accident
49 Cases
Fracture Cause
Others
12 Cases
Fracture Cause
Sport accident
15 Cases
Height173.88 cm
STANDARD_DEVIATION 6.66
Length of Hospital Stay10.83 days
STANDARD_DEVIATION 6.84
Open or Closed Fracture
Closed
83 Cases
Open or Closed Fracture
Open
1 Cases
Operated Side
Left
39 Cases
Operated Side
N/A
19 Cases
Operated Side
Right
26 Cases
Operation Time (skin-to-skin)143.21 minutes
STANDARD_DEVIATION 45.75
Sex: Female, Male
Female
16 Cases
Sex: Female, Male
Male
68 Cases
Surgical Approach
Anterior
40 Cases
Surgical Approach
Ileoinguinal
4 Cases
Surgical Approach
Kocher-Langenbeck
40 Cases
Weight78.79 kg
STANDARD_DEVIATION 13.65

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 78
other
Total, other adverse events
16 / 78
serious
Total, serious adverse events
0 / 78

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026